GH Research (GHRS) EBITDA (2020 - 2026)

GH Research's EBITDA history runs 6 years deep, the most recent figure standing at -$16.7 million for Q4 2025.

• In Q4 2025, EBITDA fell 29.15% year-over-year to -$16.7 million; the TTM figure through Dec 2025 stood at -$60.7 million (down 20.68% YoY), while the FY2025 annual figure was -$60.4 million, down 20.79% from the prior year.
• EBITDA for Q4 2025 stood at -$16.7 million, down from -$16.6 million in the prior quarter.
• The five-year high for EBITDA was -$1.1 million in Q1 2021, with the low at -$16.7 million in Q4 2025.
• The 5-year median for EBITDA is -$10.2 million (2023), against an average of -$9.9 million.
• The sharpest annual moves came in 2021 and 2025: EBITDA sank 7676.67% in 2021, then declined 10.44% in 2025.
• GH Research's EBITDA stood at -$6.6 million in 2021, then slumped by 38.53% to -$9.2 million in 2022, then decreased by 21.66% to -$11.2 million in 2023, then dropped by 16.0% to -$12.9 million in 2024, then slipped by 29.15% to -$16.7 million in 2025.
• Business Quant data shows GHRS's EBITDA at -$16.7 million in Q4 2025, -$16.6 million in Q3 2025, and -$14.7 million in Q2 2025.